Clinical Trial

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
1. To explore tissue-based biomarkers to select patients who do not respond to neoadjuvant immunotherapy (non-responders) at the point of diagnosis 2. To explore blood-based non-invasive biomarkers to predict pathological complete response (pCR) before surgery
Trial Details
NCT Number NCT06907160
Lead Sponsor Yonsei University
Conditions Clinical Stage II to III Non-Small Cell Lung Cancer
Enrollment 100 participants
Start Date 2024-08-07
Primary Completion 2026-02-28 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-02